BrainsWay down after investment in Canadian mental care provider
Seeking Alpha News (Thu, 19-Feb 2:33 PM ET)
BrainsWay Takes Minority Stake in Canadian Mental Health Provider BrainStim Health
TipRanks (Thu, 19-Feb 8:02 AM ET)
BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.
Globe Newswire (Thu, 19-Feb 7:30 AM ET)
BrainsWay gains as Cigna removes prior authorizations for depression therapy
Seeking Alpha News (Wed, 18-Feb 8:54 AM ET)
BrainsWay Highlights Evernorth Move to Drop Prior Authorization for TMS Coverage
TipRanks (Wed, 18-Feb 7:57 AM ET)
Globe Newswire (Wed, 18-Feb 7:30 AM ET)
BrainsWay to Implement 1-for-1 ADS-to-Ordinary Share Ratio in March 2026
TipRanks (Tue, 17-Feb 7:57 AM ET)
BrainsWay to change in ADS ratio to 1-for-1, effective March 3
Seeking Alpha News (Tue, 17-Feb 7:54 AM ET)
BrainsWay Announces Change in ADS-to-Ordinary Share Ratio
Globe Newswire (Tue, 17-Feb 7:30 AM ET)
BrainsWay Announces Draft Coverage Policy from Highmark for Accelerated Deep TMS
Globe Newswire (Wed, 21-Jan 7:30 AM ET)
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Brainsway Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol BWAY.
As of February 20, 2026, BWAY stock price climbed to $24.12 with 95,321 million shares trading.
BWAY has a beta of 1.19, meaning it tends to be more sensitive to market movements. BWAY has a correlation of 0.16 to the broad based SPY ETF.
BWAY has a market cap of $472.96 million. This is considered a Small Cap stock.
Last quarter Brainsway Ltd. - American Depositary Shares reported $14 million in Revenue and $.04 earnings per share. This beat revenue expectation by $470,850 and missed earnings estimates by -$.03.
In the last 3 years, BWAY traded as high as $26.63 and as low as $1.38.
The top ETF exchange traded funds that BWAY belongs to (by Net Assets): IZRL, APIE, EHLS.
BWAY has outperformed the market in the last year with a price return of +113.1% while the SPY ETF gained +13.7%. BWAY has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +59.6% and +15.2%, respectively, while the SPY returned +4.3% and +1.7%, respectively.
BWAY support price is $22.78 and resistance is $25.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BWAY shares will trade within this expected range on the day.
